Home
>
National Drug Code (NDC)
>
PROLEUKIN
PROLEUKIN - 0078-0495-61 - (Aldesleukin)
Drug Information of PROLEUKIN
| Product NDC: | 0078-0495 |
| Proprietary Name: | PROLEUKIN |
| Non Proprietary Name: | Aldesleukin |
| Active Ingredient(s): | 1.1 mg/mL & nbsp; Aldesleukin |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of PROLEUKIN
| Product NDC: | 0078-0495 |
| Labeler Name: | Novartis Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA103293 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19920506 |
Package Information of PROLEUKIN
| Package NDC: | 0078-0495-61 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 BOX (0078-0495-61) > 1 mL in 1 VIAL, SINGLE-USE |
NDC Information of PROLEUKIN
| NDC Code | 0078-0495-61 |
| Proprietary Name | PROLEUKIN |
| Package Description | 1 VIAL, SINGLE-USE in 1 BOX (0078-0495-61) > 1 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 0078-0495 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Aldesleukin |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19920506 |
| Marketing Category Name | BLA |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | ALDESLEUKIN |
| Strength Number | 1.1 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Increased Lymphocyte Activation [PE],Increased Lymphocyte Cell Production [PE],Interleukin-2 [Chemical/Ingredient],Lymphocyte Growth Factor [EPC] |
